The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...
While Mounjaro was cleared for use in England last year, Lilly put its launch on hold until its pre-filled injection device, ...
After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...
NHS England plans a phased rollout of tirzepatide to treat severe obesity, with early trials showing significant weight loss.
The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback